| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Chief Patient &Ext Af Off | EVP, Chief Patient Officer | EVP, CRO
1 company
Sachdev Amit is an EVP Chief Patient &Ext Af Off at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $31.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sell | 3,489 | $243.56 | $849,780.18 | -1.7% | |
| Feb 11, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sell | 13,070 | $246.08 | $3,216,310.52 | -4.1% | |
| Feb 3, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sale+OE | 4,097 | $231.11 | $946,845.32 | -2.1% | |
| Jan 16, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sale+OE | 5,000 | $235.00 | $1,175,000.00 | -12.1% | |
| Jan 8, 2020 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sale+OE | 5,000 | $230.00 | $1,150,000.00 | -12.1% | |
| Dec 9, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sale+OE | 5,000 | $225.00 | $1,125,000.00 | -13.0% | |
| Nov 25, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sale+OE | 5,000 | $220.00 | $1,100,000.00 | -13.0% | |
| Nov 19, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sale+OE | 5,000 | $215.00 | $1,075,000.00 | -13.0% | |
| Nov 15, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sell | 57 | $205.95 | $11,739.15 | -0.2% | |
| Nov 4, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Patient Officer | Sale+OE | 4,097 | $200.34 | $820,794.64 | -3.8% |